Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

David Becton

Concepts (167)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hemophilia A
2
2009
25
0.600
 Why?
Antineoplastic Combined Chemotherapy Protocols
6
2011
1000
0.520
 Why?
Leukemia, Myeloid, Acute
4
2010
180
0.410
 Why?
Osteosarcoma
2
2016
45
0.340
 Why?
von Willebrand Diseases
1
2009
22
0.330
 Why?
Hematology
1
2009
26
0.320
 Why?
Sclerotherapy
2
2020
46
0.320
 Why?
Antineoplastic Agents
5
2016
1176
0.300
 Why?
Vascular Malformations
2
2020
98
0.290
 Why?
Blood Coagulation Factor Inhibitors
1
2007
3
0.290
 Why?
Hemophilia B
1
2007
5
0.290
 Why?
Hemostasis, Surgical
1
2007
12
0.280
 Why?
Blood Coagulation Factors
1
2007
17
0.280
 Why?
Enoxaparin
1
2007
27
0.280
 Why?
Child, Preschool
13
2020
3896
0.280
 Why?
Blood Loss, Surgical
1
2007
73
0.270
 Why?
Venous Thrombosis
1
2007
88
0.260
 Why?
Cisplatin
3
2016
275
0.260
 Why?
Cyclosporine
1
2005
65
0.250
 Why?
Blood Coagulation Disorders
2
2020
38
0.250
 Why?
Leukemia
1
2005
64
0.240
 Why?
Hemostasis
2
2020
56
0.240
 Why?
Cladribine
1
2004
3
0.240
 Why?
Bone Regeneration
2
2016
72
0.230
 Why?
Histiocytosis, Langerhans-Cell
1
2004
32
0.230
 Why?
Retinoblastoma
1
2003
15
0.220
 Why?
Retinal Neoplasms
1
2003
13
0.220
 Why?
Infant
11
2018
3584
0.220
 Why?
Neoplasms
3
2012
1233
0.210
 Why?
Neoplasms, Second Primary
1
2003
74
0.200
 Why?
Child
14
2020
6862
0.200
 Why?
Bone Neoplasms
1
2003
178
0.190
 Why?
Thrombelastography
1
2020
25
0.180
 Why?
Adolescent
11
2020
6459
0.180
 Why?
Bleomycin
1
2018
34
0.150
 Why?
Down Syndrome
3
2008
91
0.150
 Why?
Antibiotics, Antineoplastic
1
2018
77
0.140
 Why?
Osteogenesis, Distraction
2
2016
78
0.140
 Why?
Piperazines
2
2016
118
0.140
 Why?
Leukemia, Megakaryoblastic, Acute
2
2006
6
0.130
 Why?
Leukemia, Myeloid
2
2008
42
0.130
 Why?
Humans
21
2020
50201
0.130
 Why?
Disease-Free Survival
5
2010
450
0.130
 Why?
Male
13
2020
25572
0.120
 Why?
Remission Induction
4
2011
206
0.120
 Why?
Imidazoles
1
2016
128
0.120
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
2009
84
0.120
 Why?
Leukocyte Count
2
2005
72
0.110
 Why?
Receptors, Tumor Necrosis Factor, Type I
1
2013
40
0.110
 Why?
Survival Analysis
4
2010
670
0.100
 Why?
Doxorubicin
2
2005
234
0.100
 Why?
Cord Blood Stem Cell Transplantation
1
2011
5
0.100
 Why?
Sarcoma, Myeloid
1
2011
19
0.100
 Why?
Neutropenia
1
2012
114
0.090
 Why?
Heart Neoplasms
1
2011
32
0.090
 Why?
Treatment Outcome
7
2018
5203
0.090
 Why?
Core Binding Factors
1
2010
2
0.090
 Why?
Proto-Oncogene Proteins c-kit
1
2010
36
0.090
 Why?
Female
10
2020
26829
0.080
 Why?
Entamoebiasis
1
2009
2
0.080
 Why?
Diarrhea, Infantile
1
2009
5
0.080
 Why?
Listeriosis
1
2009
7
0.080
 Why?
Liver Abscess
1
2009
5
0.080
 Why?
Anemia, Aplastic
1
2009
10
0.080
 Why?
Platelet Transfusion
1
2009
28
0.080
 Why?
Histocompatibility Testing
1
2008
12
0.080
 Why?
Acute Lung Injury
1
2009
25
0.080
 Why?
Young Adult
5
2020
4052
0.080
 Why?
HLA Antigens
1
2008
53
0.080
 Why?
Abdominal Pain
1
2009
84
0.080
 Why?
Bone Marrow Transplantation
1
2008
112
0.080
 Why?
Hospitals, Pediatric
1
2009
235
0.080
 Why?
Retrospective Studies
6
2018
6190
0.080
 Why?
Adult
7
2020
13486
0.070
 Why?
Infusions, Intravenous
2
2004
213
0.070
 Why?
Cardiomyopathies
1
2008
116
0.070
 Why?
Mitolactol
1
2005
2
0.060
 Why?
GATA1 Transcription Factor
1
2005
7
0.060
 Why?
Karyotyping
1
2005
83
0.060
 Why?
Gene Expression Regulation, Neoplastic
2
2006
824
0.060
 Why?
Tamoxifen
1
2005
59
0.060
 Why?
Heart
1
2008
336
0.060
 Why?
Receptor Protein-Tyrosine Kinases
1
2004
51
0.060
 Why?
Immunosuppressive Agents
1
2005
226
0.060
 Why?
Proto-Oncogene Proteins
1
2004
150
0.060
 Why?
Humerus
1
2003
18
0.050
 Why?
Arkansas
1
2009
1988
0.050
 Why?
Tibia
1
2003
115
0.050
 Why?
Mutation
2
2010
1288
0.050
 Why?
Methotrexate
1
2003
73
0.050
 Why?
Survivors
1
2003
120
0.050
 Why?
Topotecan
1
2002
17
0.050
 Why?
Automation
1
2002
18
0.050
 Why?
Tumor Necrosis Factor-alpha
2
2013
388
0.050
 Why?
Blood Coagulation Tests
1
2020
19
0.050
 Why?
Dose-Response Relationship, Drug
1
2004
1356
0.050
 Why?
Blood Flow Velocity
1
2020
100
0.040
 Why?
Blood Coagulation
1
2020
58
0.040
 Why?
Follow-Up Studies
2
2018
2188
0.040
 Why?
Prognosis
3
2012
1963
0.040
 Why?
Gene Expression Profiling
1
2004
1029
0.040
 Why?
Mice, Inbred C57BL
2
2016
1782
0.040
 Why?
Hemorrhage
1
2020
196
0.040
 Why?
Daunorubicin
2
2008
12
0.040
 Why?
Cytarabine
2
2006
40
0.030
 Why?
Mice, Nude
1
2016
252
0.030
 Why?
Xenograft Model Antitumor Assays
1
2016
212
0.030
 Why?
Random Allocation
1
2016
288
0.030
 Why?
Acute Disease
2
2008
368
0.030
 Why?
Cluster Analysis
2
2005
233
0.030
 Why?
Prospective Studies
2
2012
2396
0.030
 Why?
Oligonucleotide Array Sequence Analysis
2
2005
409
0.030
 Why?
Interleukin-3
1
2012
13
0.030
 Why?
Calcitonin Gene-Related Peptide
1
2012
23
0.030
 Why?
Protein Precursors
1
2012
43
0.030
 Why?
Calcitonin
1
2012
30
0.030
 Why?
Sensitivity and Specificity
2
2006
871
0.020
 Why?
Interleukin-8
1
2012
86
0.020
 Why?
Interleukin-10
1
2012
83
0.020
 Why?
ROC Curve
1
2012
236
0.020
 Why?
Fatal Outcome
1
2011
195
0.020
 Why?
Mice, Knockout
1
2013
840
0.020
 Why?
Interleukin-6
1
2012
266
0.020
 Why?
Intensive Care Units
1
2012
224
0.020
 Why?
Animals
2
2016
13141
0.020
 Why?
Pilot Projects
1
2012
703
0.020
 Why?
Exons
1
2010
95
0.020
 Why?
Time Factors
2
2008
2909
0.020
 Why?
Opportunistic Infections
1
2009
58
0.020
 Why?
Echocardiography
1
2011
390
0.020
 Why?
Mitoxantrone
1
2008
9
0.020
 Why?
Translocation, Genetic
1
2010
263
0.020
 Why?
Hospitalization
1
2012
665
0.020
 Why?
Proportional Hazards Models
1
2008
408
0.020
 Why?
Recurrence
1
2008
660
0.020
 Why?
Genetic Predisposition to Disease
1
2010
508
0.020
 Why?
Prevalence
1
2010
960
0.020
 Why?
Immunophenotyping
1
2006
111
0.020
 Why?
Tomography, X-Ray Computed
1
2011
1160
0.020
 Why?
Nucleic Acid Hybridization
1
2005
55
0.020
 Why?
Luciferases
1
2005
50
0.020
 Why?
Cell Membrane
1
2006
249
0.020
 Why?
Diagnosis, Differential
1
2009
1041
0.020
 Why?
Middle Aged
1
2020
12356
0.020
 Why?
DNA Primers
1
2005
207
0.020
 Why?
Transfection
1
2005
354
0.020
 Why?
Tumor Cells, Cultured
1
2005
462
0.010
 Why?
Core Binding Factor Alpha 3 Subunit
1
2004
1
0.010
 Why?
fms-Like Tyrosine Kinase 3
1
2004
16
0.010
 Why?
Benzamides
1
2004
50
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
579
0.010
 Why?
Magnetic Resonance Imaging
1
2011
1529
0.010
 Why?
Risk Assessment
1
2008
1255
0.010
 Why?
Risk Factors
1
2012
3644
0.010
 Why?
Mice
1
2013
5673
0.010
 Why?
Pyrimidines
1
2004
192
0.010
 Why?
Nuclear Proteins
1
2004
242
0.010
 Why?
DNA Helicases
1
2004
144
0.010
 Why?
Predictive Value of Tests
1
2004
921
0.010
 Why?
DNA-Binding Proteins
1
2004
424
0.010
 Why?
Drug Administration Schedule
1
2002
369
0.010
 Why?
Linear Models
1
2002
279
0.010
 Why?
Neutrophils
1
2002
148
0.010
 Why?
Analysis of Variance
1
2002
563
0.010
 Why?
Transcription Factors
1
2004
563
0.010
 Why?
Patient Selection
1
2002
254
0.010
 Why?
Infant, Newborn
1
2006
2770
0.010
 Why?
Becton's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (167) concept(s)
_
Co-Authors Expand Description
See all (14) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department